Tocilizumab for Relapsing Polychondritis

Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis

This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.

Inclusion Criteria:

• A single patient with unremitting inflammatory relapsing polychondritis

Exclusion Criteria:

• As this is a study in a single patient, there are no exclusions